Shares of Indian drugmakers surged 4% on Thursday, in contrast to the drop in the broader stock market, after U.S. President Donald Trump’s administration exempted pharmaceutical products from the list of imports hit by reciprocal tariffs.
© 2024 Asian Ai News LLC. All rights reserved. | Privacy Policy | Terms And Conditions
Automated page speed optimizations for fast site performance